Establishing Competitive Advantage In Dermatology Trials: Critical Study Design And Operational Considerations For A New Age

By Jasmina Jankicevic, Lori Lombardo and Kristi Miller

Skin diseases are the fourth leading cause of health afflictions, affecting nearly 900 million people worldwide.^1,2 At the same time, there has been a remarkable increase in dermatology drug development activity in recent years. For conditions such as atopic dermatitis, psoriasis, and melanoma, there are hundreds of ongoing or planned clinical trials.³ In this new and extremely competitive era, there is more pressure than ever to optimize your clinical development strategy and planning for successful study recruitment, retention, and implementation.

In this blog post, based on our recent webinar, we explore critical study design and operational success factors for this new wave of dermatology clinical trials.